Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein–Barr virus infection

por Casey, J.L., Coley, A.M., Parisi, K., Foley, M.
Publicado 2009

Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments

por Casey, J L, Pedley, R B, King, D J, Green, A J, Yarranton, G T, Begent, R H J
Publicado 1999

Isolation of antibodies specific to a single conformation-dependant antigenic determinant on the EG95 hydatid vaccine

por Read, A.J., Casey, J.L., Coley, A.M., Foley, M., Gauci, C.G., Jackson, D.C., Lightowlers, M.W.
Publicado 2009

Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle.

por Casey, J. L., King, D. J., Pedley, R. B., Boden, J. A., Boden, R., Chaplin, L. C., Dorning, M., Begent, R. H.
Publicado 1998

Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.

por Casey, J. L., King, D. J., Chaplin, L. C., Haines, A. M., Pedley, R. B., Mountain, A., Yarranton, G. T., Begent, R. H.
Publicado 1996

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F...

por Lane, D. M., Eagle, K. F., Begent, R. H., Hope-Stone, L. D., Green, A. J., Casey, J. L., Keep, P. A., Kelly, A. M., Ledermann, J. A., Glaser, M. G.
Publicado 1994

Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study

por Casey, J L, Napier, M P, King, D J, Pedley, R B, Chaplin, L C, Weir, N, Skelton, L, Green, A J, Hope-Stone, L D, Yarranton, G T, Begent, R H J
Publicado 2002